KATHRYN ODOM: Open Payments
NPI 1053865956 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,460 in 60 payments from 15 companies in 2025. Trend: 2023 $888 · 2024 $867 · 2025 $1,460
Food & beverage: $1,460
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. | 12 | $377 |
| ViiV Healthcare Company | 15 | $332 |
| Insmed, Inc. | 4 | $121 |
| Merck Sharp & Dohme LLC | 5 | $117 |
| Melinta Therapeutics, LLC | 4 | $103 |
| Aimmune Therapeutics, Inc. | 3 | $74 |
| Cumberland Pharmaceuticals, Inc. | 3 | $66 |
| ABBVIE INC. | 4 | $58 |
| La Jolla Pharmaceutical Company | 2 | $47 |
| Paratek Pharmaceuticals, Inc. | 2 | $38 |
Products named: APRETUDE, Arikayce, Rezzayo, CABENUVA, PIFELTRO, VOWST, VIBATIV, DOVATO.
Industry payments across GA — which companies pay providers there.
